SCHEMBL22853082

SCHEMBL22853082

Cc1cc(F)ccc1Nc1cc(F)c(Cl)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 2/20 0.53
MAPK13 O15264 1/20 0.49
MAPK12 P53778 1/20 0.49
MAPK11 Q15759 1/20 0.49
MAPK14 Q16539 1/20 0.49
FABP3 P05413 2/20 0.49
FABP4 P15090 2/20 0.49
FTO Q9C0B1 2/20 0.47
IDO1 P14902 1/20 0.44
P2RY4 P51582 1/20 0.44
DHODH Q02127 2/20 0.41
MKNK2 Q9HBH9 1/20 0.41
AVPR2 P30518 1/20 0.41
OXTR P30559 1/20 0.41
AVPR1A P37288 1/20 0.41
POLB P06746 1/20 0.40
MPO P05164 1/20 0.40
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30294669 1.00 CLCN2 (0.53) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL30294647 0.95 CLCN2 (0.53) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL30294377 0.89 IDO1 (0.48) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL22853121 0.89 IDO1 (0.48) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL30294798 0.87 MAPK13 (0.47) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL22852997 0.87 MAPK13 (0.47) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL22853350 0.85 CLCN2 (0.49) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL30294815 0.85 CLCN2 (0.49) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL22853346 0.85 IDO1 (0.50) CLCN2MAPK13MAPK12MAPK11MAPK14
SCHEMBL30294440 0.85 IDO1 (0.50) CLCN2MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020261114-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-12-30 WO disclosed